สีปกติ
ขาวดำ
ดำ-เหลือง
Health Products
Health Products
| No. | Title | Status | Download |
|---|---|---|---|
| 231 | NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: Specification of Active Ingredient Levels in Hazardous Substances under the Responsibility of the Food and Drug Administration That Shall Be Deemed as Fake Hazardous Substances, B.E. 2567 (2024) |  |
|
| 232 | NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: Product Notification of Type 1 Hazardous Substances under the Responsibility of the Food and Drug Administration, B.E. 2567 (2024) | |
|
| 233 | NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: Registration, Issuance of A Certificate and Renewal of the Registration Certificate for Hazardous Substances under the Responsibility of the Food and Drug Administration (No.4), B.E. 2567 (2024) | |
|
| 234 | Public Manual: Application for Transit of Type 1, Type 2, or Type 3 Hazardous Substances and Application for Amendment of Transit Permit Details | |
|
| 235 | NOTIFICATION OF THE FOOD AND DRUG ADMINISTRATION RE: Rules, Procedures, and Conditions for Notification, Application, and Issuance of Transit Permits for Hazardous Substances under the Responsibility of the Food and Drug Administration B.E. 2564 (2021) | |
|
| 236 | Documents or Evidence Indicating That Pharmaceutical Chemicals Are Produced by the Places of Production with Manufacturing Quality Certification | |
|
| 237 | Self-Checklist for Document Submission for the Application for Traditional Drug Formula Registration | |
|
| 238 | Self-Checklist for Document Submission for the Application for Modern Veterinary Drug Formula Registration | |
|
| 239 | NOTIFICATION OF THE FOOD AND DRUG ADMINISTRATION RE: RULES, PROCEDURES AND CONDITIONS FOR ISSUANCE OF NOTIFICATION LETTERS ON THE EVALUATION RESULTS OF THE MANUFACTURING STANDARDS OF OVERSEAS HERBAL PRODUCT MANUFACTURING PLACES | |
|
| 240 | NOTIFICATION OF THE FOOD AND DRUG ADMINISTRATION RE: DOCUMENTS OR EVIDENCE PRESENTING INFORMATION REGARDING QUALITY, EFFICACY AND SAFETY OF DRUGS FOR THE RENEWALS OF CERTIFICATES OF DRUG REGISTRATIONS AND RULES AND CONDITIONS FOR THE CONSIDERATION OF INFORMATION REGARDING QUALITY, EFFICACY AND SAFETY OF DRUGS | |